| A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA KJ Ishii, C Coban, H Kato, K Takahashi, Y Torii, F Takeshita, H Ludwig, ... Nature immunology 7 (1), 40-48, 2006 | 971 | 2006 |
| Nonreplicating vaccinia vector efficiently expresses recombinant genes. G Sutter, B Moss Proceedings of the National Academy of Sciences 89 (22), 10847-10851, 1992 | 840 | 1992 |
| Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence H Meyer, G Sutter, A Mayr Journal of general virology 72 (5), 1031-1038, 1991 | 682 | 1991 |
| IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice V Bronte, P Serafini, C De Santo, I Marigo, V Tosello, A Mazzoni, ... The Journal of Immunology 170 (1), 270-278, 2003 | 642 | 2003 |
| A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus G Sutter, LS Wyatt, PL Foley, JR Bennink, B Moss Vaccine 12 (11), 1032-1040, 1994 | 430 | 1994 |
| Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in … VM Hirsch, TR Fuerst, G Sutter, MW Carroll, LC Yang, S Goldstein, ... Journal of Virology 70 (6), 3741-3752, 1996 | 387 | 1996 |
| Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and … I Drexler, K Heller, B Wahren, V Erfle, G Sutter Journal of general virology 79 (2), 347-352, 1998 | 323 | 1998 |
| Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells S Halle, HC Dujardin, N Bakocevic, H Fleige, H Danzer, S Willenzon, ... Journal of Experimental Medicine 206 (12), 2593-2601, 2009 | 305 | 2009 |
| Modified vaccinia virus Ankara: history, value in basic research, and current perspectives for vaccine development A Volz, G Sutter Advances in virus research 97, 187-243, 2017 | 294 | 2017 |
| An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels BL Haagmans, JMA Van Den Brand, VS Raj, A Volz, P Wohlsein, ... Science 351 (6268), 77-81, 2016 | 289 | 2016 |
| Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase G Sutter, M Ohlmann, V Erfle FEBS letters 371 (1), 9-12, 1995 | 273 | 1995 |
| Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery G Sutter, C Staib Current Drug Targets-Infectious Disorders 3 (3), 263-271, 2003 | 249 | 2003 |
| In vivo killing capacity of cytotoxic T cells is limited and involves dynamic interactions and T cell cooperativity S Halle, KA Keyser, FR Stahl, A Busche, A Marquardt, X Zheng, M Galla, ... Immunity 44 (2), 233-245, 2016 | 237 | 2016 |
| Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and … H Horton, TU Vogel, DK Carter, K Vielhuber, DH Fuller, T Shipley, ... Journal of virology 76 (14), 7187-7202, 2002 | 235 | 2002 |
| Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential? I Drexler, C Staib, G Sutter Current opinion in biotechnology 15 (6), 506-512, 2004 | 210 | 2004 |
| Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies F Song, R Fux, LB Provacia, A Volz, M Eickmann, S Becker, ... Journal of virology 87 (21), 11950-11954, 2013 | 188 | 2013 |
| IL-17–induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs H Fleige, S Ravens, GL Moschovakis, J Bölter, S Willenzon, G Sutter, ... Journal of Experimental Medicine 211 (4), 643-651, 2014 | 187 | 2014 |
| Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma J Bukur, V Rebmann, H Grosse-Wilde, H Luboldt, H Ruebben, I Drexler, ... Cancer research 63 (14), 4107-4111, 2003 | 183 | 2003 |
| Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates B Moss, MW Carroll, LS Wyatt, JR Bennink, VM Hirsch, S Goldstein, ... Novel Strategies in the Design and Production of Vaccines, 7-13, 1996 | 178 | 1996 |
| Identification of vaccinia virus epitope-specific HLA-A* 0201-restricted T cells and comparative analysis of smallpox vaccines I Drexler, C Staib, W Kastenmüller, S Stevanović, B Schmidt, ... Proceedings of the National Academy of Sciences 100 (1), 217-222, 2003 | 177 | 2003 |
